Examine the fairness and sufficiency of the transfers to the states, especially in light of the changing center-state fiscal relations, and discuss the role played by the Finance Commission in the devolution of financial resources between the Union and state ...
Model Answer Introduction Intellectual Property Rights (IPRs) play a crucial role in fostering innovation, particularly in the biotechnology and pharmaceutical sectors. Despite India being the second-largest patent filer globally, the commercialization of these patents remains alarmingly low. PresenRead more
Model Answer
Introduction
Intellectual Property Rights (IPRs) play a crucial role in fostering innovation, particularly in the biotechnology and pharmaceutical sectors. Despite India being the second-largest patent filer globally, the commercialization of these patents remains alarmingly low.
Present World Scenario of IPRs on Life Materials
- Biotechnological Innovation: Patents on life materials, such as those related to gene editing technologies like CRISPR-Cas9, are essential for protecting innovations and maintaining market leadership.
- Intellectual Property Disputes: The increasing number of disputes over biotechnological patents, such as the BRCA1 and BRCA2 gene patents, highlights the ethical complexities involved in patenting life forms.
- Global Compliance with TRIPS: The TRIPS agreement mandates minimum IPR standards, allowing countries like India to implement compulsory licensing for essential medicines, ensuring public health.
- Protection of Indigenous Knowledge: Initiatives like India’s Traditional Knowledge Digital Library (TKDL) aim to protect traditional knowledge from biopiracy, blocking unauthorized patents on resources like turmeric and neem.
- Variability in Patent Laws: Differences in patent laws across regions affect the protection of biotechnological inventions, complicating the commercialization landscape.
Reasons for Low Commercialization of Patents in India
- Inadequate R&D Infrastructure: India’s research facilities often lack the advanced technology required to develop market-ready products.
- Financial Barriers: High costs associated with patent filing and commercialization deter startups and small enterprises from pursuing their innovations.
- Regulatory Delays: Lengthy and complex regulatory processes hinder timely commercialization of biotech products.
- Weak Industry-Academia Links: Insufficient collaboration between academic institutions and industries limits the transition of patented technologies to the market.
- Challenges in IP Enforcement: Weak enforcement of IPRs and prolonged legal disputes discourage investment in commercialization efforts.
Conclusion
To enhance the commercialization of patents in India, it is essential to improve funding, streamline regulatory processes, and strengthen collaborations between academia and industry. These steps will help bridge the gap between innovation and market application, ultimately boosting India’s position in the global biotechnology landscape.
See less



See less